External Validation of a Predictive Model for Bowel Preparation in Patients Undergoing Colonoscopy

July 26, 2020 updated by: Yanglin Pan, Air Force Military Medical University, China
Bowel preparation is closely lined to the quality of colonoscopy, inadequate bowel preparation (IBP) could lead to higher miss rate of adenomas, patients' discomfort and higher health expense. For the patients with possible IBP before the examination, it may be better to cancel the colonoscopy and repeat bowel preparation through modified or enhanced strategies. This study aimed to externally validate the efficiency of a procedure-based model in predicting inadequate bowel preparation

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Fujian
      • Xiamen, Fujian, China, 361000
        • Department of Gastroenterology, Hongai Hospital
      • Xiamen, Fujian, China
        • Xiang'an Hospital of Xiamen University
    • Hainan
      • Qionghai, Hainan, China
        • Department of Gastroenterology, Qionghai people's hospital
    • Hebei
      • Shijiazhuang, Hebei, China
        • Department of Gastroenterology, Bethune international peace hospital
    • Henan
      • Zhengzhou, Henan, China
        • Department of Gastroenterology,Zhengzhou Central Hospital
    • Shaanxi
      • Xi'an, Shaanxi, China, 710005
        • Department of gastroenterology, Shaanxi Second People's Hospital
      • Xi'an, Shaanxi, China, 710032
        • Endoscopic center, Xijing Hospital of Digestive Diseases
      • Xi'an, Shaanxi, China
        • The Second Affiliated Hospital of Xi'an Jiaotong University
    • Shannxi
      • Xi'an, Shannxi, China
        • The First Affiliated Hospital of Xi'an Medical University
    • Shanxi
      • Taiyuan, Shanxi, China
        • Department of Gastroenterology,Shanxi Bethune hospital
    • Sichuang
      • Chengdu, Sichuang, China
        • Department of Gastroenterology,Chengdu third people's hospital
    • Xinjiang
      • Shihezi, Xinjiang, China, 832008
        • Department of Gastroenterology, The First Affiliated Hospital of the Medical College, Shihezi University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

This is a prospective study involving eleven tertiary-centers in China.

Description

Inclusion Criteria:

  • Age≥18
  • Patient undergoing colonoscopy

Exclusion Criteria:

  • Patients with prior colectomy
  • Unable to provide written informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adequate bowel preparation
Time Frame: 1 hour
Defined by each segmental BBPS≥2
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The rate of yellow, clear stool in the last defecation
Time Frame: 1 hour
The characteristics of the last stool was self-evaluated by patients based on a picture containing different kind of stool examples.
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 23, 2020

Primary Completion (Actual)

May 30, 2020

Study Completion (Actual)

June 30, 2020

Study Registration Dates

First Submitted

March 26, 2020

First Submitted That Met QC Criteria

March 26, 2020

First Posted (Actual)

March 27, 2020

Study Record Updates

Last Update Posted (Actual)

July 28, 2020

Last Update Submitted That Met QC Criteria

July 26, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • KT20200324-3

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe